Janney Montgomery Scott’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.13M Buy
47,996
+3,729
+8% +$327K 0.01% 1073
2026
Q1
$4M Buy
44,267
+7,992
+22% +$733K 0.01% 945
2025
Q4
$3.26M Sell
36,275
-664
-2% -$63K 0.01% 1103
2025
Q3
$3.64M Buy
36,939
+1,810
+5% +$179K 0.01% 1026
2025
Q2
$3.2M Buy
35,129
+9,482
+37% +$917K 0.01% 998
2025
Q1
$2.9M Buy
25,647
+118
+0.5% +$12.6K 0.01% 1002
2024
Q4
$2.7M Sell
25,529
-340
-1% -$36.5K 0.01% 1029
2024
Q3
$2.79M Buy
25,869
+16,663
+181% +$1.82M 0.01% 977
2024
Q2
$999K Sell
9,206
-4,706
-34% -$555K ﹤0.01% 1444
2024
Q1
$1.84M Sell
13,912
-9,383
-40% -$1.17M 0.01% 1196
2023
Q4
$2.83M Buy
23,295
+4,141
+22% +$462K 0.01% 967
2023
Q3
$2.15M Sell
19,154
-1,328
-6% -$169K 0.01% 985
2023
Q2
$2.98M Buy
20,482
+2,326
+13% +$316K 0.01% 890
2023
Q1
$2.35M Sell
18,156
-1,020
-5% -$128K 0.01% 916
2022
Q4
$2.44M Buy
19,176
+179
+0.9% +$20.8K 0.01% 932
2022
Q3
$1.99M Sell
18,997
-6,305
-25% -$692K 0.01% 966
2022
Q2
$2.68M Sell
25,302
-8,853
-26% -$1.05M 0.01% 810
2022
Q1
$4.37M Buy
34,155
+2,788
+9% +$336K 0.02% 630
2021
Q4
$3.87M Sell
31,367
-383
-1% -$50.1K 0.02% 708
2021
Q3
$4.51M Sell
31,750
-351
-1% -$51.6K 0.02% 626
2021
Q2
$5.01M Buy
32,101
+888
+3% +$144K 0.02% 585
2021
Q1
$4.85M Buy
31,213
+564
+2% +$87.4K 0.02% 559
2020
Q4
$4.58M Buy
30,649
+446
+1% +$63K 0.02% 566
2020
Q3
$3.99M Sell
30,203
-1,087
-3% -$142K 0.02% 554
2020
Q2
$3.63M Buy
31,290
+772
+3% +$89K 0.02% 551
2020
Q1
$3M Sell
30,518
-2,228
-7% -$292K 0.02% 548
2019
Q4
$4.76M Sell
32,746
-6,546
-17% -$904K 0.03% 479
2019
Q3
$5.24M Sell
39,292
-256
-0.6% -$33.1K 0.04% 419
2019
Q2
$4.52M Sell
39,548
-24,733
-38% -$2.9M 0.03% 457
2019
Q1
$7.97M Sell
64,281
-5,756
-8% -$654K 0.07% 307
2018
Q4
$7.05M Sell
70,037
-6,500
-8% -$731K 0.07% 299
2018
Q3
$9.77M Buy
76,537
+1,161
+2% +$138K 0.08% 259
2018
Q2
$8.15M Buy
75,376
+90
+0.1% +$9.79K 0.08% 269
2018
Q1
$7.97M Sell
75,286
-224
-0.3% -$26K 0.08% 263
2017
Q4
$8.85M Buy
75,510
+10,795
+17% +$1.22M 0.09% 232
2017
Q3
$7.36M Buy
64,715
+18,638
+40% +$2.15M 0.08% 254
2017
Q2
$5.74M Buy
46,077
+2,220
+5% +$263K 0.07% 288
2017
Q1
$5.2M Sell
43,857
-3,724
-8% -$422K 0.07% 291
2016
Q4
$4.77M Buy
47,581
+907
+2% +$97.2K 0.07% 284
2016
Q3
$5.89M Buy
+46,674
New +$5.77M 0.1% 211
2016
Q2
Sell
-19,428
Closed -$2.01M 1196
2016
Q1
$2.01M Buy
19,428
+819
+4% +$79.2K 0.05% 324
2015
Q4
$1.85M Buy
18,609
+1,324
+8% +$130K 0.05% 367
2015
Q3
$1.58M Buy
17,285
+6,422
+59% +$644K 0.04% 391
2015
Q2
$1.15M Buy
10,863
+38
+0.4% +$4.21K 0.02% 712
2015
Q1
$1.24M Buy
10,825
+306
+3% +$34.9K 0.02% 778
2014
Q4
$1.16M Sell
10,519
-1,220
-10% -$129K 0.02% 793
2014
Q3
$1.15M Buy
11,739
+136
+1% +$13.4K 0.02% 769
2014
Q2
$1.17M Buy
11,603
+1,195
+11% +$117K 0.03% 738
2014
Q1
$956K Buy
10,408
+2,001
+24% +$184K 0.02% 775
2013
Q4
$761K Sell
8,407
-380
-4% -$32.9K 0.02% 850
2013
Q3
$701K Buy
8,787
+4,646
+112% +$366K 0.02% 812
2013
Q2
$301K Buy
+4,141
New +$310K 0.03% 538

Other funds holding ZBH

Janney Montgomery Scott's ZBH Position: Q2 2026 in Review

Janney Montgomery Scott increased its Zimmer Biomet (ZBH) stake by 8.4% in Q2 2026, buying an estimated $327K and bringing the position to 47,996 shares worth $4.13M. The position accounts for 0.01% of the portfolio, ranked #1073.

Janney Montgomery Scott first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.77M in Q3 2018. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Janney Montgomery Scott held 47,996 shares of Zimmer Biomet worth $4.13M as of Q2 2026.
  • Janney Montgomery Scott bought 3,729 Zimmer Biomet shares in Q2 2026, an estimated $327K.
  • Zimmer Biomet made up 0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1073 holding.
  • Janney Montgomery Scott first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Janney Montgomery Scott's Zimmer Biomet position peaked at $9.77M in Q3 2018.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.